Views & Analysis PPRS and devolution: over £60m to Greater Manchester? Does the local NHS in England get its fair share of PPRS money?
Views & Analysis Access to cancer drugs: planning for every outcome New UK oncology drug assessment procedures examined.
News ADA: AZ reveals oral GLP-1 data in obesity, diabetes AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
